Suppression of Ras-stimulated transformation by the JNK signal transduction pathway

AUTOR(ES)

Kennedy, Norman J.

FONTE

Cold Spring Harbor Laboratory Press

RESUMO

The c-Jun NH2-terminal kinase (JNK) phosphorylates and activates members of the activator protein-1 (AP-1) group of transcription factors and is implicated in oncogenic transformation. To examine the role of JNK, we investigated the effect of JNK deficiency on Ras-stimulated transformation. We demonstrate that although JNK does play a role in transformation in vitro, JNK is not required for tumor development in vivo. Importantly, the loss of JNK expression resulted in substantial increases in the number and growth of tumor nodules in vivo. Complementation assays demonstrated that this phenotype was caused by JNK deficiency. These data demonstrate that, in contrast to expectations, the normal function of JNK may be to suppress tumor development in vivo. This conclusion is consistent with the presence in human tumors of loss-of-function mutations in the JNK pathway.

Documentos Relacionados

• Hydrolysis of phosphatidylcholine is stimulated by Ras proteins during mitogenic signal transduction.
• MKK7 is an essential component of the JNK signal transduction pathway activated by proinflammatory cytokines
• Oncogene activation of human keratin 18 transcription via the Ras signal transduction pathway.
• Signal transduction by tumor necrosis factor mediated by JNK protein kinases.
• Possible involvement of normal p21 H-ras in the insulin/insulinlike growth factor 1 signal transduction pathway.